Tongrentang Tongke Pharmaceutical Wastewater Treatment Project, Beijing, China
Pharmaceutical Wastewater Treatment System | UASB + MBR + Advanced Biological Process | EPC Delivery
1 Project Overview
The Tongrentang Tongke Pharmaceutical Wastewater Treatment Project is a pharmaceutical wastewater treatment upgrade project located in Tongzhou District, Beijing, China.
The project is invested and operated by Beijing Tongrentang Tongke Pharmaceutical Co., Ltd., a subsidiary of the Tongrentang Group.
The system is designed to treat high-concentration organic wastewater generated from traditional Chinese medicine (TCM) production processes, ensuring stable compliance with strict environmental discharge standards.
2 Project Information
| Item | Details |
|---|---|
| Project Name | Tongrentang Tongke Pharmaceutical Wastewater Treatment Project |
| Location | Tongzhou District, Beijing, China |
| Project Type | Pharmaceutical Wastewater Treatment |
| Treatment Capacity | 500 m³/day |
| Industry | Traditional Chinese Medicine Manufacturing |
| Service Scope | EPC / System Upgrade |
| Core Process | Pretreatment + UASB + MBR |
| Discharge Standard | Local Class A / Surface water discharge standard |
3 Client Challenges
- High COD concentration (up to ~8000 mg/L)
- Complex organic compounds (sugars, alkaloids, lignin, pigments)
- Large fluctuations in influent water quality
- High requirements for stable biological treatment performance
- Strict environmental compliance requirements in Beijing
- Need for system upgrade within existing plant constraints
Core Challenge
Achieve stable treatment of high-strength pharmaceutical wastewater with strong fluctuation and complex organic composition under strict discharge standards
4 Engineering Solution
SYNERAQUA implemented a multi-stage biological treatment system optimized for high-load pharmaceutical wastewater.
Process Flow
Pharmaceutical Wastewater → Physicochemical Pretreatment → UASB Anaerobic Reactor → MBR System → Advanced Filtration → Disinfection → Compliance Discharge
The system combines high-efficiency anaerobic digestion with membrane bioreactor technology to ensure stable COD removal and effluent quality.
5 Scope of Work
- Process design and system optimization
- Wastewater treatment system upgrade
- Equipment supply and integration
- Electrical and instrumentation works
- Automation and control system
- Installation and commissioning
- Operator training and technical support
6 Key Technologies & Highlights
- High-load UASB anaerobic system
- Membrane Bioreactor (MBR) technology
- Advanced physicochemical pretreatment
- Stable biological treatment under fluctuating load
- Automated monitoring and control system
7 Performance Results
- Treatment capacity: 500 m³/day
- Effluent COD: < 30 mg/L
- COD removal efficiency: >95%
- System stability: >99%
- Fully automated operation achieved
8 Project Value
The project significantly improves wastewater compliance and environmental performance for pharmaceutical production, ensuring stable and sustainable operation of traditional Chinese medicine manufacturing processes.
Key contributions include:
- Stable compliance with strict discharge standards
- Significant improvement in COD removal efficiency
- Enhanced operational stability of pharmaceutical wastewater system
- Support for green transformation of TCM industry
- Reduced environmental risk and improved sustainability
